82 related articles for article (PubMed ID: 1347185)
1. Calcium antagonist therapy prevents chronic cyclosporine nephrotoxicity after renal transplantation: a prospective study.
Morales JM; Andres A; Rodriguez Paternina E; Alcazar JM; Montoyo C; Rodicio JL
Transplant Proc; 1992 Feb; 24(1):89-91. PubMed ID: 1347185
[No Abstract] [Full Text] [Related]
2. Renal transplantation: nifedipine for the nonstarters? A prospective randomised study.
Donnelly PK; Feehally J; Jurewicz A; Furness P; McCullough T; Harper SJ; Moorhouse J; Morgan J; Kehinde EO; Horsburgh T
Transplant Proc; 1993 Feb; 25(1 Pt 1):600-1. PubMed ID: 8438431
[No Abstract] [Full Text] [Related]
3. Long-term protective effect of a calcium antagonist on renal function in hypertensive renal transplant patients on cyclosporine therapy: a 5-year prospective randomized study.
Morales JM; Rodriguez-Paternina E; Araque A; Andres A; Hernandez E; Ruilope LM; Rodicio JL
Transplant Proc; 1994 Oct; 26(5):2598-9. PubMed ID: 7940807
[No Abstract] [Full Text] [Related]
4. Calcium channel blockers and early cyclosporine nephrotoxicity after renal transplantation: a prospective randomized study.
Morales JM; Andrés A; Alvarez C; Prieto C; Ortuño B; Ortuño T; Paternina ER; Hernandez Poblete G; Praga M; Ruilope LM
Transplant Proc; 1990 Aug; 22(4):1733-5. PubMed ID: 2389446
[No Abstract] [Full Text] [Related]
5. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
Suwelack B; Kobelt V; Erfmann M; Hausberg M; Gerhardt U; Rahn KH; Hohage H
Transpl Int; 2003 May; 16(5):313-20. PubMed ID: 12759722
[TBL] [Abstract][Full Text] [Related]
6. Effect of nifedipine on renal haemodynamics and urinary protein excretion in stable renal transplant recipients.
Wilkie ME; Beer JC; Raftery MJ; Dawnay A; Barton C; Marsh FP
Transplant Proc; 1993 Feb; 25(1 Pt 1):612-5. PubMed ID: 8438435
[No Abstract] [Full Text] [Related]
7. FK 506 in a 14-year-old renal allograft recipient with cyclosporine-related liver nephrotoxicity: 1-year follow-up.
Offner G; Burdelski M; Hoyer PF; Winkler M; Brodehl J
Transplant Proc; 1991 Dec; 23(6):3082-4. PubMed ID: 1721366
[No Abstract] [Full Text] [Related]
8. High-dose cyclosporine A induction therapy in liver transplant recipients with normal postoperative renal function: a prospective study.
Cherqui D; Duvoux C; Salvat A; Lauzet JY; Metreau JM; Julien M; Fagniez PL; Dhumeaux D
Transplant Proc; 1995 Feb; 27(1):1134-5. PubMed ID: 7878824
[No Abstract] [Full Text] [Related]
9. Renal function and tubular phosphate handling in long-term cyclosporine- and tacrolimus-based immunosuppression in kidney transplantation.
Falkiewicz K; Kamińska D; Nahaczewska W; Boratyńska M; Owczarek H; Klinger M; Woźniak M; Patrzałek D; Szyber P
Transplant Proc; 2006; 38(1):119-22. PubMed ID: 16504680
[TBL] [Abstract][Full Text] [Related]
10. Pentoxifylline as an adjunct to cyclosporine-based immunosuppression does not improve the outcome of renal transplantation.
Königsrainer A; Aichberger C; Riedmann B; Steurer W; Ofner D; Margreiter R
Transplant Proc; 1995 Feb; 27(1):1062-3. PubMed ID: 7878805
[TBL] [Abstract][Full Text] [Related]
11. Long-term beneficial effects of a nifedipine-supplemented immunosuppressive regimen in kidney transplantation.
Shin GT; Cheigh JS; Riggio RR; Suthanthiran M; Stubenbord WT; Serur D; Wang JC; Rubin A; Stenzel KH
Transplant Proc; 1996 Jun; 28(3):1309-10. PubMed ID: 8658672
[No Abstract] [Full Text] [Related]
12. Diltiazem treatment with reduced dose of cyclosporine in renal transplant recipients.
Wahlberg J; Hanås E; Bergström C; Fellström B; Skarp-Orberg I; Frödin L
Transplant Proc; 1992 Feb; 24(1):311-2. PubMed ID: 1539291
[No Abstract] [Full Text] [Related]
13. Protocol biopsies in stable renal transplant patients under triple immunosuppression: results at 6 months.
Rush DN; Jeffery JR; Gough J
Transplant Proc; 1994 Oct; 26(5):2576. PubMed ID: 7940797
[No Abstract] [Full Text] [Related]
14. Cadaveric renal transplantation with cyclosporine monotherapy.
Aikawa A; Sells RA; Bakran A; Tewari A
Transplant Proc; 1994 Aug; 26(4):1915-6. PubMed ID: 8066623
[No Abstract] [Full Text] [Related]
15. Clinical evaluation of cyclosporine monitoring in blood by specific and nonspecific radioimmunoassay methods in renal transplant patients with stable renal function and nephrotoxicity.
Sabaté I; Castelao AM; Santos P; Bover J; Martínez JM; Ruiz R; González de la Presa B; Moliner R; Palencia T; Griñó JM
Transplant Proc; 1995 Aug; 27(4):2254-5. PubMed ID: 7652796
[No Abstract] [Full Text] [Related]
16. Role of ACE inhibitors in the treatment of erythrocytosis in patients with renal allograft.
Pisani F; Tisone G; Alciati E; Vennarecci G; Pieragostini E; Casciani CU
Transplant Proc; 1994 Oct; 26(5):2602-3. PubMed ID: 7940809
[No Abstract] [Full Text] [Related]
17. Effect of calcium channel antagonists on renal function in hypertensive heart transplant recipients.
Bunke M; Ganzel B
J Heart Lung Transplant; 1992; 11(6):1194-9. PubMed ID: 1457446
[TBL] [Abstract][Full Text] [Related]
18. Effect of captopril, an angiotensin converting enzyme inhibitor, on the massive proteinuria due to chronic rejection after renal transplantation--a prospective study.
Morales JM; Andres A; Montoyo C; Praga M; Alcazar JM; Algranati L; Rodicio JL
Transplant Proc; 1992 Feb; 24(1):92-3. PubMed ID: 1539354
[No Abstract] [Full Text] [Related]
19. Six-month clinical outcome of cyclosporine microemulsion formulation (Sigmasporin Microral) in stable renal transplant patients previously maintained on sandimmun neoral.
Al Wakeel JS; Shaheen FA; Mathew MC; Abou Zeinab HM; Al Alfi A; Tarif NM; Al Mousawi MS; Mahmoud TS; Alorrayed AS; Fagir EA; Dham RS; Shaker DS
Transplant Proc; 2008 Sep; 40(7):2245-51. PubMed ID: 18790205
[TBL] [Abstract][Full Text] [Related]
20. Management of moderate to severe hypertension and proteinuria by nifedipine retard and perindopril after renal transplantation.
Grekas D; Dioudis C; Kalevrosoglou I; Papoulidou F; Goutsaridis N; Alivanis P; Tourkantonis A
Clin Nephrol; 1995 Nov; 44(5):299-302. PubMed ID: 8605709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
